Molly Chiaramonte

Företagsledare/Principal på

RP Management LLC

Finance

Consumer Services

Health Technology

Profil

Molly Chiaramonte is currently working as the Vice President-Research & Investments at RP Management LLC since 2011.
Prior to this, she worked as a Senior Vice President-Research & Investments at Royalty Pharma Plc from 2008 to 2021.
Before that, Molly was a Research Associate at Jefferies LLC from 2006 to 2008.
She completed her undergraduate degree at Providence College and holds graduate and doctorate degrees from The University of Colorado.

Aktiva positioner av Molly Chiaramonte

Företag	Position	Start
RP Management LLC RP Management LLC Financial ConglomeratesFinance Provides biopharma royalty transactions services	Företagsledare/Principal	2011-11-23

Alla aktiva positioner av Molly Chiaramonte

Tidigare kända positioner av Molly Chiaramonte

Företag	Position	Slut
ROYALTY PHARMA PLC	Företagsledare/Principal	2021-06-01
Jefferies LLC Jefferies LLC Investment Banks/BrokersFinance Provides brokerage services	Analyst-Equity	2008-04-30

Se detaljerna i Molly Chiaramontes erfarenhet

Molly Chiaramontes utbildningar

Erfarenheter
Innehade positioner

Aktiva

Inaktiva

Börsnoterade företag

Privata företag

Se detaljerna i Molly Chiaramontes erfarenhet

Relationer

Första gradens relationer

Företag kopplade till första graden

Man

Kvinna

Styrelseledamöter

Chefer

Se det personliga nätverket

Kopplade företag

Privata företag	5
Jefferies LLC Jefferies LLC Investment Banks/BrokersFinance Provides brokerage services	Finance
Providence College Providence College Other Consumer ServicesConsumer Services Functions as a College/University	Consumer Services
The University of Colorado The University of Colorado Other Consumer ServicesConsumer Services Functions as a College/University	Consumer Services
RP Management LLC RP Management LLC Financial ConglomeratesFinance Provides biopharma royalty transactions services	Finance
Royalty Pharma Plc Royalty Pharma Plc Pharmaceuticals: MajorHealth Technology Buys and operates a portfolio of biopharmaceutical royalties	Health Technology